SOST-Related Sclerosing Bone Dysplasia Latest Advances

Find the Latest Research About SOST-Related Sclerosing Bone Dysplasia

Find a DoctorCondition OverviewLatest AdvancesClinical TrialsTreatments

Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 175 publications

Clinical Characteristics and Management of Rare Metabolic Bone Diseases: An Audit of the Rare Metabolic Bone Disease Registry of India.

Clinical Characteristics and Management of Rare Metabolic Bone Diseases: An Audit of the Rare Metabolic Bone Disease Registry of India.

Journal: Calcified tissue international
Published: May 26, 2025

Novel Loss of Function Variant in SOST From Chinese Family Results in Sclerosteosis 1.

Novel Loss of Function Variant in SOST From Chinese Family Results in Sclerosteosis 1.

Journal: Molecular genetics & genomic medicine
Published: November 28, 2024

Long-term clinical and bone mineral density changes of adult patients with sclerostin deficiency due to van Buchem disease: a follow-up study.

Long-term clinical and bone mineral density changes of adult patients with sclerostin deficiency due to van Buchem disease: a follow-up study.

Journal: JBMR plus
Published: October 03, 2024

Therapeutic targeting of Wnt antagonists by small molecules for treatment of osteoporosis.

Therapeutic targeting of Wnt antagonists by small molecules for treatment of osteoporosis.

Journal: Biochemical pharmacology
Published: June 05, 2024

Porcupine inhibition is a promising pharmacological treatment for severe sclerosteosis pathologies.

Porcupine inhibition is a promising pharmacological treatment for severe sclerosteosis pathologies.

Journal: Bone research
Published: May 31, 2024

Sclerostin: clinical insights in muscle-bone crosstalk.

Sclerostin: clinical insights in muscle-bone crosstalk.

Journal: The Journal of international medical research
Published: August 26, 2023

An Additional Lrp4 High Bone Mass Mutation Mitigates the Sost-Knockout Phenotype in Mice by Increasing Bone Remodeling.

An Additional Lrp4 High Bone Mass Mutation Mitigates the Sost-Knockout Phenotype in Mice by Increasing Bone Remodeling.

Journal: Calcified tissue international
Published: July 10, 2023

Mef2c regulates bone mass through Sost-dependent and -independent mechanisms.

Mef2c regulates bone mass through Sost-dependent and -independent mechanisms.

Journal: Bone
Published: May 31, 2023

Novel insights on the effect of sclerostin on bone and other organs.

Novel insights on the effect of sclerostin on bone and other organs.

Journal: The Journal of endocrinology
Published: January 25, 2023

LRP4 site-specific variants in the third β-propeller domain causes congenital myasthenic syndrome type 17.

LRP4 site-specific variants in the third β-propeller domain causes congenital myasthenic syndrome type 17.

Journal: European journal of medical genetics
Published: January 23, 2023

Inhibiting WNT secretion reduces high bone mass caused by Sost loss-of-function or gain-of-function mutations in Lrp5.

Inhibiting WNT secretion reduces high bone mass caused by Sost loss-of-function or gain-of-function mutations in Lrp5.

Journal: Bone research
Published: January 02, 2023

Sostdc1 Suppression in the Absence of Sclerostin Potentiates Anabolic Action of Cortical Bone in Mice.

Sostdc1 Suppression in the Absence of Sclerostin Potentiates Anabolic Action of Cortical Bone in Mice.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: November 28, 2022
Showing 1-12 of 175

Last Updated: 10/31/2025

For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved